Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Gore wins FDA approval for modified catheter delivery system
The improved delivery catheter enhances the previous version of the Gore Tag thoracic endoprosthesis by adding a soft flexible tip to the leading end of the delivery system.
The improved delivery catheter enhances the previous version of the Gore Tag thoracic endoprosthesis by adding a soft flexible tip to the leading end of the delivery system.
The action is part of an overall cost-cutting program as the company works toward resuming full operation. The company has encountered a number of substantial challenges over the
The milestone payment arises from a drug discovery agreement between Schering-Plough and Pharmacopeia wherein Pharmacopeia contributed to Schering-Plough’s medicinal chemistry optimization of compounds discovered by Schering-Plough. Ligand completed
Fourth Quarter Results Net earnings were $118.1 million, against fourth quarter 2007 net earnings of $114.4 million. Excluding restructuring and other special items recorded in 2008 and 2007,
Mr Lehner reports to Marc Cluzel, senior vice president of R&D at Sanofi-Aventis. The chief medical officer will also chair the internal benefit/risk assessment committee created in 2008
The two-year project ‘drug discovery for bone and joint protection: structural biology for novel targets and their inhibitors’ focuses on Galapagos’s novel drug targets and the candidate drugs
Antisoma and Novartis have a worldwide development and commercialization agreement for ASA404. Trials in breast cancer will be in addition to two ongoing pivotal Phase III trials in
Emergent BioSolutions has signed a marketing agreement with Biological E for the marketing of BioThrax in India. BioThrax is the only vaccine for the prevention of anthrax infection
Dr Halpern was most recently director of regulatory affairs and head of technical regulatory affairs, North America for GlaxoSmithKline Biologicals. Dr Halpern has received her bachelor’s degree in
With this acquisition, Biotest Pharmaceuticals now operates 11 plasma centers in various locations throughout the US. In 2008, the company announced it had aggressive plans for further expansion